Meningitis B Outbreak Prompts Emergency Vaccination Programme at University of Kent
Health Secretary Wes Streeting has announced a targeted vaccination initiative for students residing in halls of residence at the University of Kent in Canterbury. This urgent response follows an unprecedented outbreak of meningitis B, with officials working diligently to contain the spread of infection.
Unprecedented and Rapidly Developing Situation
Addressing MPs in the Commons, Mr Streeting described the outbreak as both unprecedented and rapidly evolving. He confirmed that the vaccination programme will commence in the coming days, specifically targeting students who are unlikely to have received the meningitis B vaccine previously.
"This is an unprecedented outbreak. It is also a rapidly developing situation," Mr Streeting stated. He explained that while the MenB vaccine has been part of routine NHS childhood immunisations since 2015, most university students would not have been vaccinated under that schedule.
Current Case Numbers and Public Health Response
The UK Health Security Agency (UKHSA) has reported 15 confirmed cases of meningitis in Kent, an increase from the previously reported 13 cases. Tragically, this total includes two young people who have died from the infection. All 15 cases required hospital admission, with four specifically confirmed as meningitis B.
In addition to the vaccination programme, hundreds of individuals are being urged to obtain antibiotics as a preventive measure. Four dedicated sites across Kent have been established to distribute these antibiotics efficiently.
Review of Vaccine Eligibility and Response Timeline
Mr Streeting has requested that the Joint Committee on Vaccination and Immunisation (JCVI) re-examine eligibility criteria for meningitis vaccines for broader population groups. This request comes after the JCVI previously determined that a catch-up campaign for older children was not cost-effective.
"In light of this latest outbreak, I will be asking them to re-examine eligibility for meningitis vaccines," the Health Secretary told Parliament. "I will do so without prejudicing their decision because we have to follow the clinical advice on this."
Responding to criticism about the speed of public notification, Mr Streeting expressed confidence that the UKHSA acted as quickly and comprehensively as possible in its outbreak response. He emphasised the importance of following expert clinical guidance while addressing this serious public health emergency.
